BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients

BACKGROUND: In a previous work, we identified nine founder mutations present in close to 80% of BRCA1 and BRCA2 mutation carriers, and distributed across the country. The presence of founder mutations constitutes a valuable opportunity to develop new strategies for genetic screening. Genetic tests a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, Carolina, Ortega-Hernández, Victoria, Cortez, Aracely, Carvallo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123627/
https://www.ncbi.nlm.nih.gov/pubmed/35596815
http://dx.doi.org/10.1007/s11033-022-07561-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123627/
https://www.ncbi.nlm.nih.gov/pubmed/35596815
http://dx.doi.org/10.1007/s11033-022-07561-4

Ejemplares similares